We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Dual REctcal Angiogenesis or MEK Inhibition radioTHERAPY Trial (DREAMtherapy)

This study has been terminated.
(2 DLTs had been reported from first 4 patients on lowest possible dose cohort.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01160926
First Posted: July 13, 2010
Last Update Posted: January 27, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Cancer Research UK
AstraZeneca
Information provided by (Responsible Party):
Suzanne Rowland, Christie Hospital NHS Foundation Trust
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: September 2016
  Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)